Intervention

Clopidogrel

ClinicalTrials.gov intervention label

Clinical trials24
Recruiting1
Common conditions25
Lead sponsors shown15

Clinical trials

24 shown
Clopidogrel Versus Cilostazol on VesselsNCT06402747 · 2024-04-16
RECRUITING
Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung CarcinomasNCT06872541 · 2025-01-20
ACTIVE_NOT_RECRUITING
Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusNCT04305587 · 2020-03-16
COMPLETED
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.NCT04069234 · 2019-09-15
WITHDRAWN
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes MellitusNCT03774394 · 2019-08-22
COMPLETED
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCINCT03437044 · 2018-03-14
COMPLETED
Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mgNCT03329261 · 2017-12-07
COMPLETED
Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)NCT03613857 · 2017-04-15
COMPLETED
A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial InfarctionNCT02663713 · 2017-01-01
COMPLETED
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?NCT02983214 · 2016-11-01
COMPLETED
Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary InterventionNCT02748330 · 2016-06-01
COMPLETED
Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes MellitusNCT02548650 · 2016-03-25
COMPLETED
Targeting Platelets in Chronic HIV InfectionNCT02578706 · 2015-10-01
COMPLETED
ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNtsNCT02519608 · 2015-09-01
COMPLETED
Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)NCT02457130 · 2015-04-01
UNKNOWN
Antiplatelet Therapy in HIVNCT02559414 · 2015-02-01
COMPLETED
Clopidogrel Versus Ticagrelor in Type-2 DiabetesNCT02742987 · 2014-03-01
COMPLETED
Effect of Clopidogrel on Allergen Challenge in AsthmaNCT01955512 · 2013-05-01
COMPLETED
VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to PrasugrelNCT01684813 · 2012-10-01
COMPLETED
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyNCT01743014 · 2012-07-01
UNKNOWN
Zainidip in Renal Artery StenosisNCT02594410 · 2011-09-01
COMPLETED
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelNCT01263093 · 2010-12-01
COMPLETED
Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' StudyNCT02294643 · 2009-04-01
COMPLETED
Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)NCT00642174 · 2008-04-01
COMPLETED

Common conditions

Coronary Artery Disease8Diabetes Mellitus6Diabetes Mellitus, Type 24Myocardial Infarction3Acute Coronary Syndrome1Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma1Asthma1Atherosclerosis1Cardiovascular Diseases1Chronic Kidney Disease (CKD)1Chronic Obstructive Pulmonary Disease1Coronary Angioplasty1Coronary Artery Disease (CAD)1Diabetes Mellitus Type 21Diabetes Mellitus Type II1Diabetes Mellitus. Type 21Diabetes Type 21Diabetic Nephropathy1HIV1HIV-1 Infection1Hypertension1Inflammation1Ischemic Stroke1Major Depressive Disorder1Microvascular Coronary Artery Disease1

Trial status mix

COMPLETED19
UNKNOWN2
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1

Phase mix

PHASE413
PHASE26
PHASE33
PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.